The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pediatric Epilepsy Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Epilepsy is one of the most common and challenging neurologic disorders affecting children.
The global Pediatric Epilepsy Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pediatric Epilepsy Therapeutics in various end use industries. The expanding demands from the Hospitals, Neurology Centers, Home Care Settings and Ambulatory Surgical Centers, are propelling Pediatric Epilepsy Therapeutics market. Benign Rolandic Epilepsy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Childhood Absence Epilepsy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pediatric Epilepsy Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pediatric Epilepsy Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pediatric Epilepsy Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pediatric Epilepsy Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pediatric Epilepsy Therapeutics covered in this report include Abbott Laboratories, GlaxoSmithKline, Cephalon, Pfizer, Novartis, Sunovion Pharmaceuticals, Bausch Health and Sanofi, etc.
The global Pediatric Epilepsy Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
GlaxoSmithKline
Cephalon
Pfizer
Novartis
Sunovion Pharmaceuticals
Bausch Health
Sanofi
Global Pediatric Epilepsy Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pediatric Epilepsy Therapeutics market, Segment by Type:
Benign Rolandic Epilepsy
Childhood Absence Epilepsy
Juvenile Myoclonic Epilepsy
Infantile Spasms
Lennox-Gastaut Syndrome
Global Pediatric Epilepsy Therapeutics market, by Application
Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pediatric Epilepsy Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Epilepsy is one of the most common and challenging neurologic disorders affecting children.
The global Pediatric Epilepsy Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pediatric Epilepsy Therapeutics in various end use industries. The expanding demands from the Hospitals, Neurology Centers, Home Care Settings and Ambulatory Surgical Centers, are propelling Pediatric Epilepsy Therapeutics market. Benign Rolandic Epilepsy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Childhood Absence Epilepsy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pediatric Epilepsy Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pediatric Epilepsy Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pediatric Epilepsy Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pediatric Epilepsy Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pediatric Epilepsy Therapeutics covered in this report include Abbott Laboratories, GlaxoSmithKline, Cephalon, Pfizer, Novartis, Sunovion Pharmaceuticals, Bausch Health and Sanofi, etc.
The global Pediatric Epilepsy Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
GlaxoSmithKline
Cephalon
Pfizer
Novartis
Sunovion Pharmaceuticals
Bausch Health
Sanofi
Global Pediatric Epilepsy Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pediatric Epilepsy Therapeutics market, Segment by Type:
Benign Rolandic Epilepsy
Childhood Absence Epilepsy
Juvenile Myoclonic Epilepsy
Infantile Spasms
Lennox-Gastaut Syndrome
Global Pediatric Epilepsy Therapeutics market, by Application
Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pediatric Epilepsy Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pediatric Epilepsy Therapeutics
1.1 Pediatric Epilepsy Therapeutics Market Overview
1.1.1 Pediatric Epilepsy Therapeutics Product Scope
1.1.2 Pediatric Epilepsy Therapeutics Market Status and Outlook
1.2 Global Pediatric Epilepsy Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pediatric Epilepsy Therapeutics Market Size by Region (2018-2029)
1.4 Global Pediatric Epilepsy Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Pediatric Epilepsy Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pediatric Epilepsy Therapeutics Market Size (2018-2029)
1.6.1 North America Pediatric Epilepsy Therapeutics Market Size (2018-2029)
1.6.2 Europe Pediatric Epilepsy Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size (2018-2029)
1.6.4 Latin America Pediatric Epilepsy Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size (2018-2029)
2 Pediatric Epilepsy Therapeutics Market by Type
2.1 Introduction
2.1.1 Benign Rolandic Epilepsy
2.1.2 Childhood Absence Epilepsy
2.1.3 Juvenile Myoclonic Epilepsy
2.1.4 Infantile Spasms
2.1.5 Lennox-Gastaut Syndrome
2.2 Global Pediatric Epilepsy Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pediatric Epilepsy Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pediatric Epilepsy Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pediatric Epilepsy Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pediatric Epilepsy Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pediatric Epilepsy Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pediatric Epilepsy Therapeutics Revenue Breakdown by Type (2018-2029)
3 Pediatric Epilepsy Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Neurology Centers
3.1.3 Home Care Settings
3.1.4 Ambulatory Surgical Centers
3.2 Global Pediatric Epilepsy Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pediatric Epilepsy Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Pediatric Epilepsy Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pediatric Epilepsy Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pediatric Epilepsy Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pediatric Epilepsy Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pediatric Epilepsy Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pediatric Epilepsy Therapeutics Revenue Breakdown by Application (2018-2029)
4 Pediatric Epilepsy Therapeutics Competition Analysis by Players
4.1 Global Pediatric Epilepsy Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Epilepsy Therapeutics as of 2022)
4.3 Date of Key Players Enter into Pediatric Epilepsy Therapeutics Market
4.4 Global Top Players Pediatric Epilepsy Therapeutics Headquarters and Area Served
4.5 Key Players Pediatric Epilepsy Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Pediatric Epilepsy Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Pediatric Epilepsy Therapeutics Products, Services and Solutions
5.1.4 Abbott Laboratories Pediatric Epilepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Profile
5.2.2 GlaxoSmithKline Main Business
5.2.3 GlaxoSmithKline Pediatric Epilepsy Therapeutics Products, Services and Solutions
5.2.4 GlaxoSmithKline Pediatric Epilepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline Recent Developments
5.3 Cephalon
5.3.1 Cephalon Profile
5.3.2 Cephalon Main Business
5.3.3 Cephalon Pediatric Epilepsy Therapeutics Products, Services and Solutions
5.3.4 Cephalon Pediatric Epilepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Pediatric Epilepsy Therapeutics Products, Services and Solutions
5.4.4 Pfizer Pediatric Epilepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Pediatric Epilepsy Therapeutics Products, Services and Solutions
5.5.4 Novartis Pediatric Epilepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Sunovion Pharmaceuticals
5.6.1 Sunovion Pharmaceuticals Profile
5.6.2 Sunovion Pharmaceuticals Main Business
5.6.3 Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Products, Services and Solutions
5.6.4 Sunovion Pharmaceuticals Pediatric Epilepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Sunovion Pharmaceuticals Recent Developments
5.7 Bausch Health
5.7.1 Bausch Health Profile
5.7.2 Bausch Health Main Business
5.7.3 Bausch Health Pediatric Epilepsy Therapeutics Products, Services and Solutions
5.7.4 Bausch Health Pediatric Epilepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Bausch Health Recent Developments
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business
5.8.3 Sanofi Pediatric Epilepsy Therapeutics Products, Services and Solutions
5.8.4 Sanofi Pediatric Epilepsy Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Recent Developments
6 North America
6.1 North America Pediatric Epilepsy Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pediatric Epilepsy Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Epilepsy Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pediatric Epilepsy Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Epilepsy Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pediatric Epilepsy Therapeutics Market Dynamics
11.1 Pediatric Epilepsy Therapeutics Industry Trends
11.2 Pediatric Epilepsy Therapeutics Market Drivers
11.3 Pediatric Epilepsy Therapeutics Market Challenges
11.4 Pediatric Epilepsy Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
